Read more GlaxoSmithKline stories on Newserhttp://www.newser.com/taggrid/2108/glaxosmithkline.html2009 - Newseren-usNewser Feed GeneratorTue, 24 Nov 2009 7:26:34 CSThttp://www.newser.com/story/63337/anti-smoking-chantix-zyban-pose-suicide-risk-fda.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe Food and Drug Administration is warning smokers about serious mental-illness risks of two smoking-cessation drugs, as reported suicides among their users increase. Chantix and Zyban must now carry the agency’s strongest warning label, the New York Times reports. The FDA isn’t trying to scare patients, an official says: “You...http://www.newser.com/story/63337/anti-smoking-chantix-zyban-pose-suicide-risk-fda.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 01 Jul 2009 16:59:17 CDThttp://www.newser.com/story/61868/swiss-pharma-wont-donate-swine-flu-vaccine-to-poor.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSwiss pharma giant Novartis is defying the World Health Organization by refusing to donate swine flu vaccines to the world's poor, despite the designation of H1N1 as the first pandemic in 40 years, reports the Financial Times . Last week the WHO's director general called on drug companies to show "solidarity"...http://www.newser.com/story/61868/swiss-pharma-wont-donate-swine-flu-vaccine-to-poor.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 15 Jun 2009 4:58:52 CDThttp://www.newser.com/story/56920/pharma-pushes-dow-down-83.html?utm_source=syn&utm_medium=rss&utm_campaign=tagStocks were mixed today as pharmaceuticals declined but tech saw gains, the Wall Street Journal reports. GlaxoSmithKline reported a 13% drop in first-quarter earnings; GSK, Merck and Pfizer shares dropped. Yahoo and Sandisk were up despite posting quarterly losses. The Dow fell 82.99 to close at 7,886.57....http://www.newser.com/story/56920/pharma-pushes-dow-down-83.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 22 Apr 2009 15:29:29 CDThttp://www.newser.com/story/50813/glaxo-to-cut-drug-prices-in-developing-world.html?utm_source=syn&utm_medium=rss&utm_campaign=tagGlaxoSmithKline’s new boss has proposed a radical rethinking of big pharma in developing countries: He plans to cut prices, offer portions of profits to hospitals, and loosen his firm’s grip on patents that keep prices up, the Guardian reports. “I think it's absolutely the kind of thing large global companies...http://www.newser.com/story/50813/glaxo-to-cut-drug-prices-in-developing-world.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSat, 14 Feb 2009 11:25:01 CSThttp://www.newser.com/story/44768/watershed-vaccine-may-end-malaria-toll.html?utm_source=syn&utm_medium=rss&utm_campaign=tagScientists have developed a promising vaccine against malaria, a devastating disease that kills a milion people a year, most of them young children. Trials of the breakthrough vaccine enter the final phase next year and it could be widely available by 2012, reports the Los Angeles Times . Successful trials have...http://www.newser.com/story/44768/watershed-vaccine-may-end-malaria-toll.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 09 Dec 2008 1:45:59 CSThttp://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFor the first time in years, the biotech industry is in desperate need of a lifeline, Bloomberg reports, as the economic crisis threatens to shove companies into bankruptcy and derail the development of potentially life-saving drugs. “I’m looking down the barrel of a gun,” admitted one CEO. Five such companies...http://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFri, 21 Nov 2008 13:05:01 CSThttp://www.newser.com/story/42641/big-pharma-seeks-big-profits-in-developing-nations.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe pharmaceutical industry is turning away from the US shores that helped fill its pockets and toward the developing world, the Economist reports. Massive growth has made markets like India and China too attractive to ignore, despite lower income levels and weaker patent laws. And many companies fear Barack Obama's...http://www.newser.com/story/42641/big-pharma-seeks-big-profits-in-developing-nations.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSat, 15 Nov 2008 2:47:39 CSThttp://www.newser.com/story/25958/serious-side-effects-linked-to-avandia-fosamax.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTwo new studies have linked the popular prescription drugs Fosamax and Avandia to serious side effects, Reuters reports. Fosamax, prescribed for osteoporosis, has been tied to a type of abnormal heartbeat that can cause dizziness and fatigue. Another study links Avandia, used to treat diabetes, to a double or even...http://www.newser.com/story/25958/serious-side-effects-linked-to-avandia-fosamax.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 29 Apr 2008 2:57:23 CDThttp://www.newser.com/story/20035/antidepressants-mostly-useless-study-finds.html?utm_source=syn&utm_medium=rss&utm_campaign=tagBig Pharma swallowed a bitter pill yesterday as Prozac and other antidepressants were found in a UK study to be largely ineffectual in all but the most extreme cases of depression. The meta-analysis of 47 clinical trials submitted to the FDA with licensing applications for six popular antidepressants concluded that...http://www.newser.com/story/20035/antidepressants-mostly-useless-study-finds.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 26 Feb 2008 7:41:35 CST